MIMIT Health’s Dr. Sameer Ahmed, Vascular and Interventional Radiologist, spoke at Gottlieb Memorial Hospital discussing the benefits of Prostate Artery Embolization (PAE). PAE is a minimally-invasive procedure to treat benign prostatic hypertrophy (BPH). BPH is enlargement of the prostate with compression of the urethera, the main channel for urinary flow. BPH is a common medical condition present in over 80% of men by the age of 70. Men present with lower urinary tract symptoms (LUTS), which include incomplete bladder emptying, increased frequency of urination, intermittency of the urine stream, urgency to urinate, weak stream, straining to urinate, and frequent urination at night. These symptoms of BPH are often lifestyle-limiting, and both mentally and physically stressful for patients.
Previously, the only options available for treatment of symptomatic BPH were surgical: transuretheral resection of the prostate (using an electric probe through the penile urethera to shave the inside of the prostate) and prostatectomy (surgical removal of the prostate itself). Up to 20% of patients undergoing surgery may have significant complications, including sexual dysfunction, incontinence, and bleeding requiring transfusion. Surgical procedures also require general anesthesia and usually an extended stay at the hospital.
MIMIT Health now offers prostate artery embolization as a minimally-invasive alternative to surgery. The premise of the procedure is that blocking the primary blood supply to the prostate will lead to shrinkage of prostatic tissue, which in turn will relieve symptoms associated with blocked urine flow. The safety and efficacy of the procedure has been proven in research studies and clinical trials performed in the United States and abroad since 2000. Studies have shown significant improvement in symptoms and quality of life. PAE is a safe procedure with a major complication rate of less than 1% (0.1-0.4%).
Prostate artery embolization is performed through an artery in the wrist (radial artery) or groin (common femoral artery). The procedure is performed under moderate sedation with focus on patient comfort and safety. It is an outpatient procedure and patients are discharged the same day without any significant restrictions. Most patients can return to work or their normal activities within 24 hours. It is a state-of-the-art procedure supported with ample research and clinical data, which is changing the face of the treatment of BPH.
To set up an appointment or have any questions, call MIMIT Health at (708) 486-2600.